Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof
US9975915B1 · kind B1 · utility
18Cited by
19References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 10, 2017 |
| Grant date | May 22, 2018 |
| Priority date | — |
| Expiry date | Nov 10, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure provides novel crystalline forms of nicotinoyl riboside compounds or derivatives of formula (I):wherein X−, Z1, Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, modified derivatives thereof, and phosphorylated analogs thereof, or salts, solvates, or prodrugs thereof; and methods of preparation thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.